NCT00615511View on ClinicalTrials.gov

Efficacy of Pregnenolone in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DIETARY_SUPPLEMENT

placebo pregnenolone

Sugar pill, taken twice a day

DIETARY_SUPPLEMENT

pregnenolone

500mg in tablet form taken orally twice a day

Trial Locations (3)

10065

Weill Medical College of Cornell University, New York

10605

Weill Medical College of Cornell University, White Plains

08854

University of Medicine & Dentistry of New Jersey- University Behavioral HealthCare, Piscataway

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT00615511 - Efficacy of Pregnenolone in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter